The clinical entity of KPT2D is characterised by DKA at first presentation with diabetes in people with obesity, usually of middle age, with no obvious precipitating cause and the absence of anti-GAD and anti-IA-2 antibodies. This evidence concerns the gene PTPRN and obesity due to melanocortin 4 receptor deficiency.